A crossing in therapy for hepatitis C virus genotype 2 or 3: increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration.
about
A crossing in therapy for hepatitis C virus genotype 2 or 3: increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
A crossing in therapy for hepa ...... n dose with standard duration.
@en
A crossing in therapy for hepa ...... n dose with standard duration.
@nl
type
label
A crossing in therapy for hepa ...... n dose with standard duration.
@en
A crossing in therapy for hepa ...... n dose with standard duration.
@nl
prefLabel
A crossing in therapy for hepa ...... n dose with standard duration.
@en
A crossing in therapy for hepa ...... n dose with standard duration.
@nl
P2093
P356
P1433
P1476
A crossing in therapy for hepa ...... n dose with standard duration.
@en
P2093
Chia-Yen Dai
Chung-Feng Huang
Ming-Lung Yu
Wan-Long Chuang
P304
1395-6; author reply 1396
P356
10.1002/HEP.22863
P407
P50
P577
2009-04-01T00:00:00Z